Report cover image

Technology Innovations and Growth Opportunities in Inhaled Therapeutics

Publisher Frost & Sullivan
Published Apr 27, 2023
Length 41 Pages
SKU # MC17899812

Description

Technology Innovations and Growth Opportunities in Inhaled Therapeutics


Nanoparticle-based Formulation to Drive Transformational Growth Across Inhaled Vaccines and Monoclonal Antibodies

Inhalation drug delivery involves administering drugs to the lungs through the mouth (pulmonary route) or nose (intranasal route), enabling them to bypass the blood-brain barrier. Small molecules have been the main focus for inhalation delivery, but recent R&D and increased interest in inhalable COVID-19 vaccines have led to a shift toward inhalable biologics for conditions where injection delivery is the norm.

This Frost & Sullivan study highlights important formulations for inhalable biologics and examines the factors that drive or limit market growth. The research examines the pipeline of monoclonal antibodies and vaccines in development and evaluates R&D trends, partnership and collaboration trends, funding and investment analysis, patent analysis, and the outlook for inhalable biologics. The study identifies significant growth opportunities for industry players in the field.

Questions this study answers:
1. What factors drive or limit the industry’s growth?
2. What are the innovative methods for formulating inhalable biologics?
3. What does the pipeline analysis for inhalable vaccines and monoclonal antibodies look like?
4. What are the R&D trends and projected developments of the technologies?
5. What are the funding evaluations, patent evaluations, regulatory environments, and trends for partnerships and collaborations for inhalable biologics?
6. What are the growth opportunities for technology developers in the inhalable biologics space?

Table of Contents

41 Pages
    • Why Is It Increasingly Difficult to Grow? The Strategic Imperative 8™: Factors Creating Pressure on Growth
    • The Strategic Imperative 8™
    • The Impact of the Top 3 Strategic Imperatives on the Inhaled Therapeutics Industry
    • Growth Opportunities Fuel the Growth Pipeline Engine™
    • Research Methodology
    • Scope of Analysis
    • The Need for Inhalation Biologics Formulation
    • Inhalation Drug Delivery—Introduction
    • Segmentation—Formulations for Drug Inhalation
    • Pros and Cons of Formulation and Drug Delivery Systems for Inhalation
    • Examples of Novel Formulations and Drug Delivery System for Inhalable Biologics
    • Promising Inhalation Therapy—Advantages of Inhalational Monoclonal Antibodies (mAbs) and Vaccines
    • Growth Drivers
    • Growth Restraints
    • Pipeline Analysis of Inhaled Vaccines and mAbs
    • Vaccines and mAbs under Clinical Development
    • Primary Technologies—AttenuBlock Platform Technology (Codon Deoptimization for Live Attenuated Vaccine Candidates)
    • Primary Technologies—Nanoemulsion Platform (Intranasal Adjuvant Technology)
    • R&D Trends
    • Collaboration and Partnership Trends
    • Funding and Investment Analysis
    • Patent Analysis
    • Future Roadmap
    • Growth Opportunity 1: Drug Repurposing Using Nanotechnology to Produce a Nebulizer Solution
    • Growth Opportunity 2: Partnering with a CDMO that Offers End-toend Services
    • Growth Opportunity 3: Gene-based Antibody Delivery for Safe Inhaled Administration
    • Your Next Steps
    • Why Frost, Why Now?

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us